As of 2025-09-19, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-09-05 | -4.14 |
| 2025-09-04 | -3.73 |
| 2025-09-03 | -3.73 |
| 2025-09-02 | -3.73 |
| 2025-08-29 | -3.93 |
| 2025-08-28 | -3.93 |
| 2025-08-21 | -3.93 |
| 2025-08-19 | -4.14 |
| 2025-08-18 | -3.93 |
| 2025-08-15 | -3.93 |
| 2025-08-13 | -4.14 |
| 2025-08-12 | -4.14 |
| 2025-08-07 | -3.93 |
| 2025-08-06 | -4.35 |
| 2025-08-05 | -4.35 |
| 2025-07-29 | -4.35 |
| 2025-07-28 | -4.97 |
| 2025-07-25 | -4.14 |
| 2025-07-23 | -4.56 |
| 2025-07-21 | -4.14 |
| 2025-07-18 | -4.97 |
| 2025-07-11 | -4.14 |
| 2025-07-03 | -4.14 |
| 2025-07-02 | -4.14 |
| 2025-06-30 | -3.93 |
| 2025-06-27 | -4.14 |
| 2025-06-26 | -4.14 |
| 2025-06-25 | -3.93 |
| 2025-06-24 | -4.14 |
| 2025-06-19 | -3.93 |